Home › Grants › CDC-RFA-PS-27-0008
ForecastedControlling and Preventing STIs in US Health Departments (CAP-STIs)
Federal funding opportunity CDC-RFA-PS-27-0008 from Centers for Disease Control - NCHHSTP.
View forecast on Grants.gov →Forecasted — not yet open
- Posted
- May 11, 2026
- Closes
- See announcement
- Program funding
- $500,000,000
- Expected awards
- 59
- Cost sharing
- No
- Instrument
- Cooperative Agreement
- Assistance listing
- 93.977
- Category
- Health
- Archives
- September 28, 2026
Program funding history
Awards made under Assistance Listing 93.977 across FY2024–FY2026, from public federal spending records.
- FY2024 obligated
- $122.4M
- FY2025 obligated
- $104.8M
- FY2026 (to date) obligated
- $100.4M
- Awards in window
- 234
Top recipients: Public Health, California Department of, Department of State Health Services, Florida Department of Health, City of New York, County of Los Angeles
Source: USAspending.gov · refreshed July 2026
Synopsis
CDC is funding programs that track, prevent, and control sexually transmitted infections (STI) in state, district, territorial, and city or county health departments.
The purpose of this NOFO is to track, prevent, and control three common STIs: syphilis, gonorrhea, and chlamydia.
The NOFO supports the goals of the Sexually Transmitted Infections National Strategic Plan 2021-2025:
- Prevent new STIs.
- Improve the health of people by reducing adverse outcomes of STIs.
- Implement STI prevention technology and innovations more quickly.
- Reduce the impact of STIs in areas or populations disproportionately impacted by STIs.
- Achieve integrated, coordinated efforts that address the STI epidemic.
Local surveillance data will determine the priority populations for this NOFO. Each program should focus on populations that are disproportionately impacted by STI transmission.
To be successful with this NOFO, you will need to collaborate with partners to address interconnected comorbidities and sexual health.
Who can apply
- Special district governments
- State governments
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- County governments
- City or township governments
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
All fifty (50) states, the District of Columbia, the US Virgin Islands and Puerto Rico are eligible to apply. To ensure implementation of STI control and prevention nationwide, CDC intends to fund all fifty states, the District of Columbia, the US Virgin Islands and Puerto Rico, non-competitively, according to a funding formula based on the respective jurisdiction"s population & morbidity of three reportable STIs (chlamydia, gonorrhea and primary & secondary syphilis).Section 318(c) of the Public Health Services Act, 42 USC 247c(c), provides that the Secretary of HHS may provide funding to "States and, in consultation with the State health authority, to political subdivisions of States..." to conduct STI prevention & control projects. This language allows CDC to fund cities in addition to their respective states. Under the previous STI prevention & control funding opportunity PS19-1901 (& prior to that, PS14-1402), CDC funded the following cities based upon population, STI morbidity & organizational capacity: New York City, Philadelphia, Baltimore, Chicago, Los Angeles & San Francisco.To maximize the efficiency of program delivery, CDC may again fund a limited number of cities under this award. Funding for cities will be awarded competitively, based on the same criteria shown above for the state formula: population, STI morbidity, as well as organizational capacity. Directly funded cities must have a demonstrated capacity to report chlamydia, gonorrhea and syphilis surveillance data to CDC; an agreement with their parent state to apply separately for NOFO funding & to coordinate/collaborate appropriately following any funding; & data showing that the surrounding metropolitan statistical area (MSA) reported 2024 data showing:> or = to 500 cases of syphilis aged 15-44 reported in 2024 > or = 7500 cases of gonorrhea aged 15-44 reported in 2024 > or = to 15,000 cases of chlamydia aged 15-44 reported in 2024 > or = to 4 million residents estimated in 2024 Cities that…
How to apply
Applications go through the official government listing. Grants Radar links you straight to the source.
Get grants like this every Tuesday — free
One email a week: the biggest new federal grants and what’s closing soon. Unsubscribe in one click.
Similar grants
- Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
- Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
- Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)
Never miss a funding deadline again
Grants Radar sends AI-enriched alerts on federal grants and contracts matched to what you do. Founding seats are limited and locked for life.
Get funding alerts